2021 Q1 Form 10-Q Financial Statement

#000143774921012288 Filed on May 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $8.111M $10.72M
YoY Change -24.35% 1.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $384.0K $392.0K
YoY Change -2.04% 0.77%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.985M $4.399M
YoY Change -54.88% 4.07%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.173M -$1.431M
YoY Change -181.97% -391.45%
Income Tax $319.0K -$359.0K
% Of Pretax Income 27.2%
Net Earnings $854.0K -$1.072M
YoY Change -179.66% -431.89%
Net Earnings / Revenue 10.53% -10.0%
Basic Earnings Per Share $0.22 -$0.27
Diluted Earnings Per Share $0.22 -$0.27
COMMON SHARES
Basic Shares Outstanding 3.944M 3.931M
Diluted Shares Outstanding 3.945M 3.931M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $84.27M $52.16M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $33.13M $34.31M
YoY Change -3.45% -2.9%
Goodwill $1.107M $1.107M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.30M $12.00M
YoY Change -5.83% 15.38%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $886.2M $999.6M
YoY Change -11.34% 4.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $6.400M $8.200M
YoY Change -21.95% 5.13%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.400M $8.200M
YoY Change -21.95% 5.13%
LONG-TERM LIABILITIES
Long-Term Debt $30.80M $30.90M
YoY Change -0.32% -0.32%
Other Long-Term Liabilities $2.200M $2.600M
YoY Change -15.38% 36.84%
Total Long-Term Liabilities $33.00M $33.50M
YoY Change -1.49% 1.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.400M $8.200M
Total Long-Term Liabilities $33.00M $33.50M
Total Liabilities $822.3M $935.0M
YoY Change -12.05% 5.83%
SHAREHOLDERS EQUITY
Retained Earnings -$41.74M -$39.85M
YoY Change 4.75% 12.19%
Common Stock $106.4M $106.2M
YoY Change 0.14% -0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $63.94M $64.62M
YoY Change
Total Liabilities & Shareholders Equity $886.2M $999.6M
YoY Change -11.34% 4.88%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $854.0K -$1.072M
YoY Change -179.66% -431.89%
Depreciation, Depletion And Amortization $384.0K $392.0K
YoY Change -2.04% 0.77%
Cash From Operating Activities -$834.0K -$4.313M
YoY Change -80.66% -1091.49%
INVESTING ACTIVITIES
Capital Expenditures $178.0K $3.000K
YoY Change 5833.33% -66.67%
Acquisitions
YoY Change
Other Investing Activities $45.11M -$5.520M
YoY Change -917.21% -36.41%
Cash From Investing Activities $44.93M -$5.520M
YoY Change -913.93% -36.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.543M 22.59M
YoY Change -75.46% -1555.22%
NET CHANGE
Cash From Operating Activities -$834.0K -4.313M
Cash From Investing Activities $44.93M -5.520M
Cash From Financing Activities $5.543M 22.59M
Net Change In Cash $49.64M 12.75M
YoY Change 289.26% -230.06%
FREE CASH FLOW
Cash From Operating Activities -$834.0K -$4.313M
Capital Expenditures $178.0K $3.000K
Free Cash Flow -$1.012M -$4.316M
YoY Change -76.55% -1113.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001098146
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3946576
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
PATRIOT NATIONAL BANCORP INC
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2021Q1 dei Trading Symbol
TradingSymbol
pnbk
CY2021Q1 pnbk Accrued Interest And Dividends Receivable
AccruedInterestAndDividendsReceivable
6270000
CY2020Q4 pnbk Accrued Interest And Dividends Receivable
AccruedInterestAndDividendsReceivable
6620000
CY2021Q1 pnbk Amortization And Accretion Of Purchase Loan Premiums And Discounts Net
AmortizationAndAccretionOfPurchaseLoanPremiumsAndDiscountsNet
-285000
CY2020Q1 pnbk Amortization And Accretion Of Purchase Loan Premiums And Discounts Net
AmortizationAndAccretionOfPurchaseLoanPremiumsAndDiscountsNet
-190000
CY2021Q1 pnbk Amortization Of Servicing Assets Of Sold Loans
AmortizationOfServicingAssetsOfSoldLoans
6000
CY2020Q1 pnbk Amortization Of Servicing Assets Of Sold Loans
AmortizationOfServicingAssetsOfSoldLoans
5000
CY2021Q1 pnbk Availableforsale Securities Debt Maturities Year One Through Five Amortized Cost Basis
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveAmortizedCostBasis
8783000
CY2020Q4 pnbk Availableforsale Securities Debt Maturities Year One Through Five Amortized Cost Basis
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveAmortizedCostBasis
11299000
CY2021Q1 pnbk Availableforsale Securities Debt Maturities Year One Through Five Fair Value
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveFairValue
9039000
CY2020Q4 pnbk Availableforsale Securities Debt Maturities Year One Through Five Fair Value
AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveFairValue
11539000
CY2021Q1 pnbk Banks Reserve Based On Analysis In Unfunded Commitments
BanksReserveBasedOnAnalysisInUnfundedCommitments
8000
CY2020Q4 pnbk Banks Reserve Based On Analysis In Unfunded Commitments
BanksReserveBasedOnAnalysisInUnfundedCommitments
8000
CY2015Q1 pnbk Capital Conservation Buffer
CapitalConservationBuffer
0.025
CY2021Q1 pnbk Capitalized Servicing Assets
CapitalizedServicingAssets
17000
CY2020Q1 pnbk Capitalized Servicing Assets
CapitalizedServicingAssets
2000
CY2021Q1 pnbk Commitments To Extend Credit
CommitmentsToExtendCredit
128763000
CY2020Q4 pnbk Commitments To Extend Credit
CommitmentsToExtendCredit
122394000
CY2019Q3 pnbk Common Equity Tier1 Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTier1CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.065
CY2019Q1 pnbk Common Equity Tier1 Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTier1CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.07
CY2019Q3 pnbk Community Bank Tier One Leverage Capital Required For Capital Adequacy
CommunityBankTierOneLeverageCapitalRequiredForCapitalAdequacy
10000000000
CY2019Q3 pnbk Community Bank Tier One Leverage Ratio
CommunityBankTierOneLeverageRatio
0.09
CY2021Q1 pnbk Decrease Increase In Accrued Expense And Other Liabilities
DecreaseIncreaseInAccruedExpenseAndOtherLiabilities
78000
CY2020Q1 pnbk Decrease Increase In Accrued Expense And Other Liabilities
DecreaseIncreaseInAccruedExpenseAndOtherLiabilities
-133000
CY2021Q1 pnbk Decrease Increase In Premises And Equipment
DecreaseIncreaseInPremisesAndEquipment
-130000
CY2020Q1 pnbk Decrease Increase In Premises And Equipment
DecreaseIncreaseInPremisesAndEquipment
133000
CY2021Q1 pnbk Employee Retention Tax Credit
EmployeeRetentionTaxCredit
843000
CY2021Q1 pnbk Fees And Service Charges
FeesAndServiceCharges
65000
CY2020Q1 pnbk Fees And Service Charges
FeesAndServiceCharges
114000
CY2021Q1 pnbk Financing Receivable Loans Remaining On Deferment
FinancingReceivableLoansRemainingOnDeferment
37700000
CY2021Q1 pnbk Financing Receivable Principal And Interest Deferred Payments
FinancingReceivablePrincipalAndInterestDeferredPayments
232700000
CY2021Q1 pnbk Financing Receivable Troubled Debt Restructuring Number Of Contracts
FinancingReceivableTroubledDebtRestructuringNumberOfContracts
9
CY2020Q4 pnbk Financing Receivable Troubled Debt Restructuring Number Of Contracts
FinancingReceivableTroubledDebtRestructuringNumberOfContracts
11
CY2021Q1 pnbk Gain Loss On Sale Of Sba Loans Held For Sale Net
GainLossOnSaleOfSBALoansHeldForSaleNet
94000
CY2020Q1 pnbk Gain Loss On Sale Of Sba Loans Held For Sale Net
GainLossOnSaleOfSBALoansHeldForSaleNet
12000
CY2021Q1 pnbk General Insurance Income Expense
GeneralInsuranceIncomeExpense
60000
CY2020Q1 pnbk General Insurance Income Expense
GeneralInsuranceIncomeExpense
70000
CY2020Q4 pnbk Impaired Financing Receivable Nonperforming Loans Discount To Appraisal Value Percent
ImpairedFinancingReceivableNonperformingLoansDiscountToAppraisalValuePercent
0.058
CY2021Q1 pnbk Impaired Financing Receivable Nonperforming Loans Discount To Appraisal Value Percent
ImpairedFinancingReceivableNonperformingLoansDiscountToAppraisalValuePercent
0.08
CY2021Q1 pnbk Interest Expense Notes Payable
InterestExpenseNotesPayable
4000
CY2020Q1 pnbk Interest Expense Notes Payable
InterestExpenseNotesPayable
5000
CY2021Q1 pnbk Interest Expense Senior Debt
InterestExpenseSeniorDebt
229000
CY2020Q1 pnbk Interest Expense Senior Debt
InterestExpenseSeniorDebt
229000
CY2021Q1 pnbk Loan Application Inspection Processing Fees
LoanApplicationInspectionProcessingFees
63000
CY2020Q1 pnbk Loan Application Inspection Processing Fees
LoanApplicationInspectionProcessingFees
53000
CY2021Q1 pnbk Loans Receivable Term To Reset To Fhlb Rate
LoansReceivableTermToResetToFhlbRate
P5Y
CY2021Q1 pnbk Loans Serviced By Entity But Owned By A Third Party
LoansServicedByEntityButOwnedByAThirdParty
20000000
CY2020Q4 pnbk Loans Serviced By Entity But Owned By A Third Party
LoansServicedByEntityButOwnedByAThirdParty
19400000
CY2021Q1 pnbk Material And Communications
MaterialAndCommunications
145000
CY2020Q1 pnbk Material And Communications
MaterialAndCommunications
120000
CY2020 pnbk Maximum Period For Charged Off Of Consumer Installment Loans
MaximumPeriodForChargedOffOfConsumerInstallmentLoans
P180D
CY2021Q1 pnbk Maximum Period Of Credit Extension Of Construction Loans
MaximumPeriodOfCreditExtensionOfConstructionLoans
P1Y180D
CY2021Q1 pnbk Noncash Activity Increase In Operating Lease Liabilities
NoncashActivityIncreaseInOperatingLeaseLiabilities
CY2020Q1 pnbk Noncash Activity Increase In Operating Lease Liabilities
NoncashActivityIncreaseInOperatingLeaseLiabilities
57000
CY2021Q1 pnbk Noncash Activity Increase In Operating Lease Rightofuse Assets
NoncashActivityIncreaseInOperatingLeaseRightofuseAssets
CY2020Q1 pnbk Noncash Activity Increase In Operating Lease Rightofuse Assets
NoncashActivityIncreaseInOperatingLeaseRightofuseAssets
-57000
CY2021Q1 pnbk Number Of Availableforsale Securities
NumberOfAvailableforsaleSecurities
41
CY2020Q4 pnbk Number Of Availableforsale Securities
NumberOfAvailableforsaleSecurities
37
CY2021Q1 pnbk Number Of Impaired Loans
NumberOfImpairedLoans
33
CY2020Q4 pnbk Number Of Impaired Loans
NumberOfImpairedLoans
26
CY2021Q1 pnbk Number Of Impaired Loans Collectively Evaluated For Impairment
NumberOfImpairedLoansCollectivelyEvaluatedForImpairment
10
CY2021Q1 pnbk Number Of Impaired Loans Individually Evaluated For Impairment
NumberOfImpairedLoansIndividuallyEvaluatedForImpairment
23
CY2021Q1 pnbk Payments For Origination Of Sba Loans Held For Sale
PaymentsForOriginationOfSBALoansHeldForSale
2805000
CY2020Q1 pnbk Payments For Origination Of Sba Loans Held For Sale
PaymentsForOriginationOfSBALoansHeldForSale
2566000
CY2020Q3 pnbk Payments To Acquire Prepaid Debit Card Deposits
PaymentsToAcquirePrepaidDebitCardDeposits
50000000
CY2021Q1 pnbk Period For Charged Off Of Closeend Credits
PeriodForChargedOffOfCloseendCredits
P120D
CY2021Q1 pnbk Period For Charged Off Of Openend Credits
PeriodForChargedOffOfOpenendCredits
P180D
CY2021Q1 pnbk Prepaid Debit Card Deposits
PrepaidDebitCardDeposits
68800000
CY2020Q4 pnbk Prepaid Debit Card Deposits
PrepaidDebitCardDeposits
59300000
CY2021Q1 pnbk Proceeds From Payments For Originated Loans Receivable Net
ProceedsFromPaymentsForOriginatedLoansReceivableNet
69366000
CY2020Q1 pnbk Proceeds From Payments For Originated Loans Receivable Net
ProceedsFromPaymentsForOriginatedLoansReceivableNet
11873000
CY2021Q1 pnbk Proceeds From Principal Repayments On Debt Securities Available For Sale
ProceedsFromPrincipalRepaymentsOnDebtSecuritiesAvailableForSale
3066000
CY2020Q1 pnbk Proceeds From Principal Repayments On Debt Securities Available For Sale
ProceedsFromPrincipalRepaymentsOnDebtSecuritiesAvailableForSale
1635000
CY2021Q1 pnbk Proceeds From Sale And Maturities Of Debt Securities Available For Sale
ProceedsFromSaleAndMaturitiesOfDebtSecuritiesAvailableForSale
1886000
CY2020Q1 pnbk Proceeds From Sale And Maturities Of Debt Securities Available For Sale
ProceedsFromSaleAndMaturitiesOfDebtSecuritiesAvailableForSale
CY2021Q1 pnbk Project Expenses
ProjectExpenses
10000
CY2020Q1 pnbk Project Expenses
ProjectExpenses
94000
CY2021Q1 pnbk Reclass Of Premises And Equipment To Implementation Cost
ReclassOfPremisesAndEquipmentToImplementationCost
52000
CY2020Q1 pnbk Reclass Of Premises And Equipment To Implementation Cost
ReclassOfPremisesAndEquipmentToImplementationCost
CY2021Q1 pnbk Regulatory Assessments
RegulatoryAssessments
228000
CY2020Q1 pnbk Regulatory Assessments
RegulatoryAssessments
440000
CY2019Q1 pnbk Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets With Capital Buffer
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssetsWithCapitalBuffer
0.085
CY2021Q1 pnbk Time Deposits Below Fdic Insurance Limit
TimeDepositsBelowFDICInsuranceLimit
165130000
CY2020Q4 pnbk Time Deposits Below Fdic Insurance Limit
TimeDepositsBelowFDICInsuranceLimit
160968000
CY2021Q1 pnbk Unrealized Holding Losses Depreciation Percentage From Amortized Cost
UnrealizedHoldingLossesDepreciationPercentageFromAmortizedCost
0.036
CY2020Q4 pnbk Unrealized Holding Losses Depreciation Percentage From Amortized Cost
UnrealizedHoldingLossesDepreciationPercentageFromAmortizedCost
0.04
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-89000
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-44000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-688000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-518000
CY2021Q1 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
2158000
CY2020Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
3786000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
10426000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
10584000
CY2021Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
114000
CY2020Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
41000
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
272000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
44000
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
28000
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
28000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18000
CY2021Q1 us-gaap Assets
Assets
886188000
CY2020Q4 us-gaap Assets
Assets
880729000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
496000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
491000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1423000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1189000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
58820000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
49960000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
26415000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
26772000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
25547000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
25744000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
23622000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
11889000
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
23307000
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
11979000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
57893000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
49262000
CY2021Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 54pt;"> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">1.</div></div><div style="display: inline; font-weight: bold;"> </div></div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Basis of Financial Statement Presentation</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The accompanying unaudited interim condensed consolidated financial statements of Patriot National Bancorp, Inc. (the&nbsp;&#x201c;Company&#x201d;) and its wholly-owned subsidiaries Patriot Bank, N.A. (the &#x201c;Bank&#x201d;), Patriot National Statutory Trust I and PinPat Acquisition Corporation (collectively, &#x201c;Patriot&#x201d;), have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d;) have been omitted. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included on the Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The consolidated balance sheet at <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>presented herein has been derived from the audited consolidated financial statements of the Company at that date, but does <div style="display: inline; font-style: italic; font: inherit;">not</div> include all of the information and footnotes required by US GAAP for complete financial statements.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and to disclose contingent assets and liabilities. Actual results could differ from those estimates. Management has identified accounting for the allowance for loan and lease losses, the analysis and valuation of its investment securities, the valuation of deferred tax assets, the impairment of goodwill, the valuation of derivatives, and the valuation of servicing assets as certain of the Company's more significant accounting policies and estimates, in that they are critical to the presentation of the Company's consolidated financial condition and results of operations. As they concern matters that are inherently uncertain, these estimates require management to make subjective and complex judgments in the preparation of the Company's consolidated financial statements.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; text-decoration: underline;">Reclassifications:</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Certain amounts appearing in the financial statements and notes thereto for prior periods have been reclassified to conform with the current presentation. The reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on net income or stockholders' equity as previously reported.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The information furnished reflects, in the opinion of management, all normal recurring adjustments necessary for a fair presentation of the results for the interim periods presented. The results of operations for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results of operations that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be expected for the remainder of <div style="display: inline; font-style: italic; font: inherit;">2021.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; text-decoration: underline;">COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> Impact</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In <div style="display: inline; font-style: italic; font: inherit;"> March 2020, </div>the World Health Organization declared novel coronavirus disease <div style="display: inline; font-style: italic; font: inherit;">2019</div> ("COVID-<div style="display: inline; font-style: italic; font: inherit;">19"</div>) as a global pandemic. The COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic has negatively impacted the global and U.S. economies. Many businesses in the U.S., including those in the markets we serve, were required to close, causing a significant increase in unemployment and loss of revenue.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The consolidated financial statements reflect estimates and assumptions that affect the reported amounts of assets and liabilities, including the amount of the allowance for loan losses. The assumptions and estimates used in the financial statements were impacted by the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We are unable to estimate the full impact of COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> on our business and operations at this time. The extent of such impact will depend on future developments, which are highly uncertain, including when COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> can be controlled and abated and when and how the economy <div style="display: inline; font-style: italic; font: inherit;"> may </div>be reopened. The pandemic could cause us to experience higher credit losses in our loan portfolio, impairment of our goodwill,&nbsp;additional valuation allowance associated with our net deferred tax assets, reduced demand for our products and services, or other negative impacts on our financial position, results of operations, and prospects.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <div style="display: inline; font-style: italic; font: inherit;"> March 27, 2020, </div>the President of the United States signed into law the Coronavirus Aid, Relief and Economic Security (&#x201c;CARES&#x201d;) Act in response to the coronavirus pandemic. This legislation aims at providing relief for individuals and businesses that have been negatively impacted by the coronavirus pandemic.</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <div style="display: inline; font-style: italic; font: inherit;"> August 3, 2020, </div>the Federal Financial Institutions Council issued a joint statement, encouraging financial institutions to consider prudent accommodation options to mitigate losses for the borrower and financial institution beyond the initial accommodation period. The joint statement specifically encourages financial institutions to provide consumers with available options for repaying missed payments at the end of their accommodation to avoid delinquencies, as well as options for changes to terms to support sustainable and affordable payments for the long term. These considerations should also include prudent risk management practices at the financial institution based on the credit risk of the borrower. Patriot is actively working with its customers to address any further accommodation needs while carefully evaluating the associated credit risk of the borrowers.</div> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</div> <div style=" font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Federal Reserve System (the &#x201c;Fed&#x201d;) has taken, and continues to take, steps to support markets and the economy. Stimulus from Washington and the federal government, in spite of political hurdles and a change in presidential administrations, has also provided meaningful support. The new Biden administration has adopted another <div style="display: inline; font-style: italic; font: inherit;">$1.9</div> trillion stimulus package in <div style="display: inline; font-style: italic; font: inherit;"> March 2021. </div>The market expects the Fed Funds rate to remain at the effective lower bound near <div style="display: inline; font-style: italic; font: inherit;">zero</div> for an extended period of time. Henceforth, the Fed appears to be willing to let inflation run above the <div style="display: inline; font-style: italic; font: inherit;">2%</div> target level, even when unemployment is very low, before removing accommodation.</div></div>
CY2021Q1 us-gaap Capital
Capital
98500000
CY2020Q4 us-gaap Capital
Capital
97600000
CY2019Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.105
CY2019Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.11
CY2019Q3 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1
CY2021Q1 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.11
CY2020Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.11
CY2021Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.133
CY2020Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.125
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84274000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34636000
CY2021Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
2593000
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
3006000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34636000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39404000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
84274000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
52156000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49638000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12752000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4018013
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4017313
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3944272
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3943572
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
106363000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
106329000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
684000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2414000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
17935000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
19628000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1002000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1041000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
19915000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
9208000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
421000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
148000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
37850000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
28836000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1423000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1189000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
26
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
22
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11274000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11496000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
281000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-390000
CY2021Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
48000
CY2020Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
89000
CY2021Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.5
CY2020Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4503000
CY2021Q1 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
2744000
CY2020Q4 us-gaap Federal Reserve Bank Stock
FederalReserveBankStock
2783000
CY2021Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2020Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2021Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
14497000
CY2021Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2021Q1 us-gaap Deposits
Deposits
692878000
CY2020Q4 us-gaap Deposits
Deposits
685656000
CY2021Q1 us-gaap Deposits Domestic
DepositsDomestic
692878000
CY2020Q4 us-gaap Deposits Domestic
DepositsDomestic
685656000
CY2021Q1 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
131844000
CY2020Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
146389000
CY2021Q1 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
34433000
CY2020Q4 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
30529000
CY2021Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
103025000
CY2020Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
98635000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
384000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
392000
CY2021Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
34000
CY2020Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
138000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2021Q1 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
90000000
CY2020Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
90000000
CY2021Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4503000
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
15886000
CY2021Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2020Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
331000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
343000
CY2021Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
94000
CY2020Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
12000
CY2021Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
2000
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
CY2021Q1 us-gaap Goodwill
Goodwill
1107000
CY2020Q4 us-gaap Goodwill
Goodwill
1107000
CY2021Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
23528000
CY2020Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
18865000
CY2021Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
96000
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
33000
CY2021Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
29000000
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
24400000
CY2021Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1900000
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1400000
CY2021Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
14016000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
9978000
CY2021Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
65000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
29000
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
9512000
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
8887000
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
31000
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
4000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1173000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1431000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
319000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-359000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
47000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-237000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1179000
CY2021Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-1628000
CY2020Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-1044000
CY2021Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
7222000
CY2020Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
33679000
CY2021Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-350000
CY2020Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
198000
CY2021Q1 us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
CY2020Q1 us-gaap Increase Decrease In Loans From Other Federal Home Loan Banks
IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
-10000000
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1025000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
564000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1540
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2021Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
350000
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
390000
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8111000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10722000
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7743000
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
10033000
CY2021Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
519358000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
526980000
CY2021Q1 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
519358000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
526980000
CY2021Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
81681000
CY2020Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
31630000
CY2021Q1 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
18456000
CY2020Q4 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
41287000
CY2021Q1 us-gaap Interest Expense
InterestExpense
1985000
CY2020Q1 us-gaap Interest Expense
InterestExpense
4399000
CY2021Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
785000
CY2020Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
3200000
CY2021Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
733000
CY2020Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
697000
CY2021Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
234000
CY2020Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
268000
CY2021Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6126000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
5519000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6126000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6323000
CY2021Q1 us-gaap Interest Income Operating
InterestIncomeOperating
310000
CY2020Q1 us-gaap Interest Income Operating
InterestIncomeOperating
416000
CY2021Q1 us-gaap Interest Income Other Domestic Deposits
InterestIncomeOtherDomesticDeposits
24000
CY2020Q1 us-gaap Interest Income Other Domestic Deposits
InterestIncomeOtherDomesticDeposits
135000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1836000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
4781000
CY2021Q1 us-gaap Investments
Investments
62343000
CY2020Q4 us-gaap Investments
Investments
53712000
CY2021Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
8112000
CY2020Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
8110000
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2216000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3861000
CY2021Q1 us-gaap Liabilities
Liabilities
822251000
CY2020Q4 us-gaap Liabilities
Liabilities
817510000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
886188000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
880729000
CY2021Q1 us-gaap Loan Processing Fee
LoanProcessingFee
24000
CY2020Q1 us-gaap Loan Processing Fee
LoanProcessingFee
24000
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10426000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10584000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10115000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
10916000
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
676676000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
730180000
CY2020Q4 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
CY2021Q1 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0
CY2021Q1 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
255000
CY2020Q1 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
191000
CY2021Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
2829000
CY2020Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
1217000
CY2021Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
62000
CY2020Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
147000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5543000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22585000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
44929000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5520000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-834000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4313000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
854000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1072000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
854000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1072000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
854000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1072000
CY2021Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
173520000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
158676000
CY2021Q1 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
173520000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
158676000
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
5395000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
7371000
CY2021Q1 us-gaap Noninterest Income
NoninterestIncome
442000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
421000
CY2021Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
90000
CY2020Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
111000
CY2021Q1 us-gaap Notes Payable To Bank
NotesPayableToBank
943000
CY2020Q4 us-gaap Notes Payable To Bank
NotesPayableToBank
994000
CY2021Q1 us-gaap Notes Receivable Net
NotesReceivableNet
666250000
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
719596000
CY2021Q1 us-gaap Occupancy Net
OccupancyNet
920000
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
949000
CY2021Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
130000
CY2020Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
131000
CY2021Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
6425000
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
7255000
CY2021Q1 us-gaap Other Assets
OtherAssets
9919000
CY2020Q4 us-gaap Other Assets
OtherAssets
9387000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-170000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1342000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-229000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1808000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-59000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-466000
CY2021Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
528000
CY2020Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
492000
CY2021Q1 us-gaap Other Investments
OtherInvestments
4450000
CY2020Q4 us-gaap Other Investments
OtherInvestments
4450000
CY2021Q1 us-gaap Other Real Estate
OtherRealEstate
1216000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
1906000
CY2021Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2021Q1 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2021Q1 us-gaap Payments For Proceeds From Federal Reserve Bank Stock
PaymentsForProceedsFromFederalReserveBankStock
-39000
CY2020Q1 us-gaap Payments For Proceeds From Federal Reserve Bank Stock
PaymentsForProceedsFromFederalReserveBankStock
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
13901000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0
CY2021Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
16041000
CY2020Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
19025000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
178000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2021Q1 us-gaap Proceeds From Sale Of Other Loans Held For Sale
ProceedsFromSaleOfOtherLoansHeldForSale
1006000
CY2020Q1 us-gaap Proceeds From Sale Of Other Loans Held For Sale
ProceedsFromSaleOfOtherLoansHeldForSale
144000
CY2021Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
692000
CY2020Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
CY2021Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
852000
CY2020Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
784000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33128000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33423000
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
804000
CY2021Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
CY2020Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
804000
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
51000
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41738000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42592000
CY2021Q1 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
35323000
CY2021Q1 us-gaap Time Deposits
TimeDeposits
250056000
CY2021Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
66470000
CY2020Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
49172000
CY2021Q1 us-gaap Senior Notes
SeniorNotes
11946000
CY2020Q4 us-gaap Senior Notes
SeniorNotes
11927000
CY2021Q1 us-gaap Servicing Asset
ServicingAsset
327000
CY2020Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
316000
CY2019Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
201000
CY2021Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
327000
CY2020Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
198000
CY2021Q1 us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
17000
CY2020Q1 us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
2000
CY2021Q1 us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
6000
CY2020Q1 us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
5000
CY2021Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
391000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
34000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
43000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
34000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
63219000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
63937000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
66994000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
64623000
CY2021Q1 us-gaap Subordinated Debt
SubordinatedDebt
9789000
CY2020Q4 us-gaap Subordinated Debt
SubordinatedDebt
9782000
CY2021Q1 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
89300000
CY2020Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
87800000
CY2019Q3 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.09
CY2019Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.09
CY2021Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.09
CY2020Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.09
CY2021Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.101
CY2020Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.098
CY2019Q3 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2021Q1 us-gaap Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
277000
CY2021Q1 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
1823000
CY2021Q1 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
209215000
CY2021Q1 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
3418000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3945120
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3931388
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3943580
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3931388

Files In Submission

Name View Source Status
0001437749-21-012288-index-headers.html Edgar Link pending
0001437749-21-012288-index.html Edgar Link pending
0001437749-21-012288.txt Edgar Link pending
0001437749-21-012288-xbrl.zip Edgar Link pending
ex_248742.htm Edgar Link pending
ex_248743.htm Edgar Link pending
ex_248744.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pnbk-20210331.xml Edgar Link completed
pnbk-20210331.xsd Edgar Link pending
pnbk-20210331_cal.xml Edgar Link unprocessable
pnbk-20210331_def.xml Edgar Link unprocessable
pnbk-20210331_lab.xml Edgar Link unprocessable
pnbk-20210331_pre.xml Edgar Link unprocessable
pnbk20210331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending